tiprankstipranks
In this article:
Blurbs

RBC Capital Thinks Amedisys’ Stock is Going to Recover

In this article:
In this article:

RBC Capital analyst Ben Hendrix maintained a Buy rating on Amedisys (AMEDResearch Report) on April 29 and set a price target of $199.00. The company’s shares closed last Friday at $127.65, close to its 52-week low of $122.12.

According to TipRanks.com, Hendrix is a 1-star analyst with an average return of -2.4% and a 39.3% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Brookdale Senior Living, and Bright Health Group.

Currently, the analyst consensus on Amedisys is a Moderate Buy with an average price target of $183.00, implying a 41.6% upside from current levels. In a report issued on April 27, Jefferies also maintained a Buy rating on the stock with a $200.00 price target.

See the top stocks recommended by analysts >>

The company has a one-year high of $292.97 and a one-year low of $122.12. Currently, Amedisys has an average volume of 321.9K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.

Read More on AMED:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed

In this article:

Latest News Feed